Is Grail going to go public?
Dec 17, 2021 · Grail filed a draft registration with the US Securities and Exchange Commission under the ticker symbol GRAL. Not yet an official IPO, it's one of the first steps of taking a private company public. There's no news yet about how much the stock will cost when it goes public. No date has been set for when the stock will be publicly available.
When is Grail's IPO date?
Sep 09, 2020 · Cancer detection company Grail files to go public Published: Sept. 9, 2020 at 6:30 a.m. ET
Who are the underwriters for the GRAIL Inc IPO?
Sep 09, 2020 · In Grail's filing with the SEC on Sept. 9, the company said that the IPO date would be “as soon as practicable after the effective date of this Registration Statement.” The company intends to raise...
How do I buy Grail stock?
Jun 25, 2021 · Currently, Grail isn't publicly traded on its own, although it did file for an IPO in September of 2020. Article continues below advertisement The company’s primary product, which has been in...
Is GRAIL going to go public?
Cancer blood test maker Grail files for Nasdaq IPO, eyes 2021 commercial launch. Grail, the company on a quest to spot cancers early with a simple blood test, is finally going public after raising nearly $2 billion in funding for its research since 2016.
Can I invest in GRAIL?
If Grail goes public independently, you'll be able to buy shares after the IPO happens. You can also buy shares of Illumina now — though it's unclear whether Illumina's acquisition of Grail will hold.
Did Illumina buy GRAIL?
SAN DIEGO, /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission's ongoing regulatory review.Aug 18, 2021
Is GRAIL a private or public company?
Join Over 1 Million Premium Members Receiving… Carmichael: I've not done a lot of research into Grail. It's private.Aug 8, 2021
Is Grail a good company?
Is GRAIL a good company to work for? GRAIL has an overall rating of 3.8 out of 5, based on over 76 reviews left anonymously by employees. 67% of employees would recommend working at GRAIL to a friend and 55% have a positive outlook for the business.
Will Freenome go public?
Nolan said that Freenome is well capitalized for the clinical trials. Though there are no immediate plans to pursue an IPO, Nolan said the company is keeping that path open as an option. “As long as we stay focused on our mission for patients, then we will be able to raise in the public or private markets,” he said.Jan 11, 2022
Who purchased Grail?
IlluminaIn September 2020, San Diego-based Illumina announced that it agreed to acquire Grail, a startup that spun out from Illumina nearly five years ago, for cash and stock consideration of $8 billion.Aug 19, 2021
Who acquired Grail?
IlluminaIllumina faces yet another setback from regulatory officials regarding its $8 billion acquisition of GRAIL, Inc.Mar 4, 2022
What type of company is Grail?
healthcare companyAbout us. GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection.
What stock is the Holy GRAIL?
HGRLHoly Grail Co (HGRL)
What is the stock price of GRAIL?
0.4070Performance OutlookPrevious Close0.4070Day's Range0.3870 - 0.417552 Week Range0.0075 - 0.5850Volume193,648Avg. Volume232,3483 more rows
What is GRAIL worth?
GRAIL's valuation in December 2019 was $6,000M. GRAIL's latest post-money valuation is from September 2020.
Cancer-detection company Grail, which counts Jeff Bezos among its investors, files to go public
Grail spun out of Illumina in 2015 and has a long-term agreement that requires Grail to give a small percentage of its revenue, whenever it comes, to Illumina.
Jeff Bezos-backed cancer testing company Grail files for U.S. IPO
U.S-based cancer testing startup Grail Inc, which has received funding from Amazon.com Inc founder Jeff Bezos, on Wednesday filed for a U.S. initial public offering.
Traders thought Apple had 'the holy grail' of oil data, but the quest continues
Every day, energy merchants collect and scrutinize whatever information they can find on fuel demand to get a trading edge: from satellite data tracking oil tankers worldwide to thermal images from came...
Referenced Symbols
Grail Inc., which has developed a multi-cancer early detection blood test, has filed for an initial public offering. The California-based company has not yet determined the number of shares to offer or the expected pricing of the IPO. Morgan Stanley, Goldman Sachs and BofA Securities are the lead underwriters.
Coronavirus tally: Global cases of COVID-19 top 217 million as study finds Moderna vaccine produced more antibodies than Pfizer's
The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to data aggregated by Johns Hopkins University. The U.S. leads the world with a total of 39 million cases and 638,715 deaths.
About the Author
Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.
Who owns the Grail?
Who owns Grail? Illumina is Grail’s biggest shareholder with a 14.6 percent stake in the company. Apart from Jeff Bezos, Bill Gates has invested in Grail. Johnson & Johnson Innovation, Bristol-Myers-Squibb, Celgene, and Merk have also invested in Grail.
Why is early diagnosis important?
Early diagnosis is critical to treat cancer. The survival rates are much higher if cancer is caught in the early stages.
Is early diagnosis of cancer good?
Early diagnosis is critical to treat cancer. The survival rates are much higher if cancer is caught in the early stages. Currently, credible screening only exists for a few types of cancer — a gap that Grail is trying to fill. Article continues below advertisement.
Is Grail IPO?
U.S. based cancer testing company Grail, which was founded in 2016, has filed for an IPO. Amazon CEO Jeff Bezos is among Grail’s investors. Apart from Amazon and The Washington Post, Bezos has invested in many other ventures including Airbnb, which confidentially filed for an IPO last month. Bezos also invested in Twitter before its IPO.
How much money did Grail raise?
Article continues below advertisement. Grail was a spin-out from Illumina and has raised over $2 billion in funds. Prior to the acquisition plans, Illumina was also Grail’s largest single shareholder with 14.6 percent of shares.
What is Galleri test?
The company’s primary product, which has been in development for several years, is Galleri, which is a detection test to help diagnose cancer in much earlier stages than is currently possible. Galleri is effective at detecting over 50 types of cancers. Its goal is to make earlier detection the norm, which theoretically makes cancer more treatable ...
Who is the chairman of the Glickman Urological and Kidney Institute at Cleveland Clinic?
Dr. Eric Klein, the chairman of the Glickman Urological and Kidney Institute at Cleveland Clinic, who participated in the research, said, “Finding cancer early, when treatment is more likely to be successful, is one of the most significant opportunities we have to reduce the burden of cancer.”.
Did Illumina buy the Grail?
Illumina is publicly traded on the Nasdaq under the symbol "ILMN," and its $8 million acquisition of Grail would give the company access to the groundbreaking Galleri blood test.
Does Illumina own the Grail?
Monday morning, Illumina announced a deal to pay $7.1 billion in cash and stock for the Grail shares it doesn’t own. Grail had attracted billions in outside financing.
How many cancers can a blood test detect?
Grail says it has developed a blood test that can detect 50 cancers—many of which have no current screening method for early detection. A study of Grail’s Galleri test, published in June, claimed it could avert nearly 40% of the most deadly cancers.
